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ABSTRACT
EFFECT OF SOCIO-CULTURAL BELIEFS ON LATE STAGE PRESENTATION OF BREAST
CANCER AMONG GHANAIAN WOMEN. Yehoda M. Martei; Verna Vanderpuye; and Beth A. Jones.
Yale University, School of Medicine, New Haven, CT.
New data emphasizes the increasing burden of cancer in the developing world, which has led to an
increasing move to prioritize cancer care on the global health agenda. Breast cancer is the leading cause of
cancer mortality among women globally. In Ghana, most women present with advanced stage breast
cancer. There is currently no national screening program, and insight into why women present late stage is
limited. The aim of this study is to characterize why women present with advanced stage breast cancer in
Ghana.
We used a Qualitative study based on in-person and in-depth interviews with 31 breast cancer
patients seen at the Korle-bu Teaching Hospital in Ghana. The interview data was transcribed, and coded
based on the Grounded theory method. Data was organized using NVivo 9 software.
Five recurrent themes emerged from our study with four explicitly related to late stage at
presentation: 1) Study participants expressed some awareness of breast cancer, but with varying depths of
knowledge; 2) most patients present late because they do not associate a “painless” breast lump with
possible breast malignancy; 3) women with a confirmed breast cancer diagnosis, delay treatment because of
the fear of mastectomy; 4) religion plays an important supportive role for breast cancer patients. 5) A fifth
factor was not explicitly related to delayed presentation. Breast cancer treatment presents a significant
financial burden but was not stated as an explicit reason for delayed presentation. We concluded that
despite efforts to increase awareness, there are still significant knowledge gaps, and social and cultural
factors that need to be addressed to enable patients translate this information to their personal health. The
church’s current role can be leveraged to augment current efforts to increase breast cancer awareness and
utilization of the current services available. Successful design and implementation of cancer programs
hinge on attention to socio-cultural influences on advanced stage presentation.
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INTRODUCTION

The International Agency for Research on Cancer (IARC)’s most recent cancer
statistics indicate that the majority of the 12.8 million new cancer cases (56%) and the 7.6
million cancer deaths (63%) worldwide occurred in developing countries. In developing
countries, more people develop (7.1million) and die from cancer (4.8million) each year
than are affected or die from HIV/AIDS throughout the world (an estimated 2.7 million
and 2 million respectively in 2008) (1, 2). These new data emphasize the increasing
burden of cancer in the developing world, which has led to an initiative by significant
global health players to move cancer on the global health agenda (3). However, there is
still a ring of silence surrounding cancer diagnoses in the developing world and
preliminary studies are needed to examine the perceptions of cancer in order to design
culturally appropriate and effective cancer control programs in the developing world.

Breast Cancer in Ghana
Breast cancer is the leading cause of cancer mortality among women globally. 1.1
million women in the world are diagnosed annually with breast cancer, which accounts
for more than 10% of all new cancers diagnosed per year (4). 410,000 women die of
breast cancer every year, which represents more than 1.6% of all female deaths
worldwide (5, 6). The IARC estimated WHO age-world standardized-incidence rate
(ASR (W)) for breast cancer in 2008 among women in the United States is 76.0. For the
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same year, the age-world-standardized mortality rate for breast cancer in the United
States was 14.7. The IARC calculates the ASR (W) by dividing the number of cases
within a specified age-group with the corresponding population at risk and is expressed
per million person-years. The IARC estimates for Ghana were ASR(W) incidence rate of
25.8 and ASR(W) mortality rate for breast cancer of 15.2 in 2008 (7). These data
underscore the fact that despite the significantly lower incidence rate of breast cancer
among Ghanaian women relative to American women, the breast cancer mortality burden
of the two countries are comparable.
In most developing countries, including Ghana, the incidence rate of breast cancer
is comparatively low compared to western countries. Consequently, breast cancer and
other cancers are not traditionally recognized as public health problems in these
countries. Infectious diseases are the main focus and target of public health interventions
in a majority of these countries (1, 3). In recent years however, the incidence rate of
breast cancer in developing countries has been increasing at approximately 5% per year
(8). The earliest study of breast cancer in Ghana revealed that breast cancer accounted for
7.45% of all cancers treated from 1972 to 1977 at the Korle-Bu Teaching hospital
(KBTH), one of the two main teaching hospitals in Ghana (9). Ghana does not have a
national tumor registry, so these data represent only breast cancer cases that come to
medical attention at the KBTH and cannot be extrapolated to represent the incidence of
breast cancer in Ghana. These data are useful for evaluating trends in cancer cases seen at
KBTH. The most recent data showed an increase in the relative proportion of breast
cancer cases, with breast cancer accounting for 15.4% of all malignancies seen at the
KBTH (10). A 10 year review (1991-2000) of autopsies and hospital mortality carried out
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in Ghana showed a parallel increase in breast cancer mortality - 17.24% of cancer deaths
among women were attributable to breast cancer (11). All these point to an increasing
burden of breast cancer in Ghana, which is consistent with current statistics that show an
increasing trend in breast cancer incidence and mortality in developing countries globally
(7).
Despite the relatively lower incidence of breast cancer among Ghanaian women,
the mortality rates for breast cancer are comparable or even higher in the Ghanaian
population compared to the US population (7). This observation can be explained by
several factors. Majority of the breast cancer patients in developing countries present
with advanced stage cancer, and consequently have a poor prognosis when they are
initially diagnosed (8, 12). Studies indicate that women who attend annual screening
mammograms present with smaller size tumors, which in the long-term accounts for
improvement in survival (13, 14). It can be accurately inferred that a significant fraction
of the high mortality rate in Ghana can be explained by the underutilization of
mammography screening and other screening modalities among Ghanaian women.
Recent studies have also compared breast cancer presentation and mortality patterns
between African Americans and Africans. In both populations, the breast cancer
mortality is disproportionately higher than the incidence. Similarly, the average age at
presentation for Africans and African Americans, was 10 years younger than the average
age at presentation of breast cancer patients in western nations. Data available for African
American breast cancer patients, show a stage shift toward more advanced disease, which
resulted in higher breast cancer mortality. New data has also shown the genetic
predisposition to more aggressive disease in the African American population. Whether
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this contributes to advanced stage presentation and increased breast cancer mortality in
Sub Saharan Africa remains uncertain (15).

Breast Cancer Mammography Screening
The commonest screening technique used in the detection of breast cancer
globally is screening mammography (16). Previous studies in the US and other Western
countries have shown that a significant fraction of the decrease in the breast cancer
mortality in the last couple of decades can be attributed to mammography screening. In
the US, approximately 48% of the decline in breast cancer mortality experienced from
1975-2000 can be accounted for by screening mammography (13). Similarly in the UK,
about a third of the overall 21% decrease in breast cancer mortality from 1990-1998 is
estimated to be due to screening (14). The recent controversy surrounding the revised
screening guidelines by the United States Preventive Services Task Force (USPSTF) does
not dispute the mortality benefit of mammography screening, but instead, they
recommend against screening for women younger than 50 years and older than 75 years,
because there is insufficient data to support mortality benefit in these age groups (17).
Despite the net mortality benefit of mammography screening, research preceding these
new screening recommendations show that most women in the US do not adhere to the
screening guidelines (18-22).
There is no national mammography screening program instituted in Ghana. The
main modalities of screening are the Clinical Breast Examination (CBE) and Breast SelfExamination (BSE). Previous studies show no mortality benefit of the BSE and there are
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currently no randomized trials of the CBE (23). Currently, the USPSTF does not endorse
both modalities of screening (17), but in the absence of routine screening mammography
in Ghana, most breast cancers are picked up by the BSE and CBE. There has been a
recent surge in public education programs about breast cancer and available screening
options, as well as organized mass CBE screening outreach programs organized by both
the government (national teaching hospitals) and non-governmental organizations
(NGOs) (such as Mammocare Ghana and Reach for Recovery). The KBTH is located in
Accra, the capital city of Ghana, and organizes free CBE a couple of days within the
year. Mammocare Ghana is an NGO that promotes breast cancer and screening
awareness. This NGO organizes free CBE screening through outreach programs. Reach
for Recovery Ghana is an NGO that provides a network of support for breast cancer
patients and survivors. They also organize annual breast cancer information sessions to
promote breast cancer awareness and early detection. In spite of these provisions,
mammography screening and CBE continue to be significantly underutilized among
Ghanaian women (12). The average tumor size at presentation among breast cancer
patients in Ghana is 6-7cm (12), compared to an average tumor size of 1.4cm and 1.9cm
among US women aged 50-60years and <40years respectively (24). This raises the
concern that women are not getting screening mammograms and CBEs. It further
indicates that although the Ghanaian government and NGOs are making screening more
accessible and available, the actual uptake of screening services by the population
remains poor. Successful implementation of any screening intervention necessitates an
assessment of breast cancer awareness within the population and an analysis of the
factors that explain why women present with advanced stage breast cancer. Current

10

research also suggests that even in instances where women have a confirmed diagnoses
of breast cancer, treatment follow-up is poor (25). The reasons for this remain unclear,
but are most likely socio-cultural and socioeconomic-related, and have yet to be
described.

Previous Studies
A Pubmed search for publications related to Ghana and breast cancer yielded
limited results. Few studies have looked at the knowledge of breast cancer and breast
cancer screening among women in Ghana (25). Studies in other parts of sub-Saharan
Africa have looked at perceptions of breast cancer and the depth of breast cancer
knowledge among women in Africa. The results revealed that women knew very little
about breast cancer (26-30). Additionally, less than half of family physicians and nurses
surveyed, said they regularly carried out or recommended breast cancer screening to their
patients (27, 31).
Although evidence indicates several obstacles to diagnosis and management of
breast cancer in Ghana, information to characterize the socio-cultural phenomenon is
lacking. The goal of this study is to understand the degree of breast cancer awareness
among a subset of women diagnosed with breast cancer. This study also aims to allow
participants to describe how their knowledge of breast cancer and socio-cultural factors
influenced their decision to present with symptoms and to follow up with breast cancer
treatment. The importance of this study is underscored by the fact that despite the wide
acceptance of breast cancer screening and the extensive public awareness of breast cancer
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among the American public, many women do not receive regular mammograms
according to screening guidelines (32-34). A significant body of research related to
mammography screening in the US has been directed towards understanding the
screening patterns specific to different ethnic groups (35-38). Similarly this study will
shed light on the specific factors associated with late presentation of breast cancer
symptoms and play a pivotal role in the future design and implementation of educational
tools for breast cancer screening and management in Ghana.
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METHOD

Study Design
This study used qualitative methodology as a preliminary vehicle for investigating
the above research question, because qualitative methods are well suited for studies for
which there is a paucity of prior research (39). Few studies have explored the knowledge,
attitudes and beliefs of breast cancer patients in Ghana. While previous investigators have
used a questionnaire based approach, we believe the qualitative method is more effective
in revealing salient insights into socio-cultural and socioeconomic factors that impact
breast cancer, and specifically their impact on late breast cancer presentation (40). The
qualitative approach also employs open-ended questions which allow the interviewer to
re-word and re-order questions to explore topics introduced by the respondent (41). In
this particular study, the qualitative method allows the respondents to explain their
understanding of breast cancer using their own vocabulary. The results of this qualitative
study will be useful for generating hypotheses that can be tested with quantitative
research design (39).We believe this fund of knowledge will inform the design and
implementation of educational programs to address the diagnosis and management of
breast cancer in Ghana (40, 42).

Patient Population
The research protocol was approved by the Human Investigation Committee of
the Yale University School of Medicine, New Haven, CT (HIC Protocol # 0804003745).
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The study setting is the outpatient breast clinic at the KBTH staffed by a team of
surgeons, radiation oncologists, oncology nurses, a clinical psychologist and a clinical
pharmacist, who meet every Tuesday to discuss self-referred patients. The clinic also
serves as a follow-up center for patients with confirmed breast cancer diagnosis
undergoing treatment.
31 study participants were selected using purposive sampling (39). Women with a
confirmed breast cancer diagnoses, who were attending routine follow-up appointment at
the clinic between June 2008 and August 2008, were approached in-person by one of the
authors (VV), who is a radiation oncologist at the clinic, and asked if they would
participate in research to study the perception of breast cancer among Ghanaian women.
In order to address the goal of the study, we selected women with confirmed diagnoses of
breast cancer. All the study participants had been previously seen at the clinic, and were
presenting for follow-up. Of note there was variability in the timeline of breast cancer
management in order to inform a broader understanding of factors that influence
screening and follow up at different stages of treatment. All the women who were
approached agreed to participate in the study, and were then introduced to the interviewer
(YMM), who explained the study in detail. Participants were reluctant to give written
consent, so verbal consent was obtained for all study participants, and consenting patients
were interviewed at the clinic.
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Interview and Data Collection
The interviews were conducted in English and three local Ghanaian languages –
Twi, Ga and Ewe. There were no third parties present for any of the interviews, except
for one interview in which the study participant’s daughter was present and served as an
English-Ewe translator. The interviewer (YMM) was fluent in the other languages – Twi
and Ga. The study participants were asked a series of open-ended questions about their
general health and wellbeing, previous encounters with the healthcare system, knowledge
of breast cancer, screening, presentation and treatment course, as well as their feelings
about their diagnosis, and religious and socio-cultural influences relevant to their recent
breast cancer diagnoses. The iterative process was used for this study. Preliminary data
analysis of earlier interviews occurred concurrently with data collection, and the
interview questions in subsequent interviews, were modified based on emerging themes
(42). Questions were optimized during this process in order to retain only questions that
were effective in eliciting the necessary information. A mix of both planned and
unplanned follow-up questions were carefully considered to continue the conversation
and were primarily directed by the respondent’s knowledge and interests (40). In this
setting where the vocabulary for breast cancer is not directly translatable to the local
languages, the translations during the interviews were descriptive and the meanings of the
questions were clarified by allowing the respondents to first express the understanding of
the question in their own words before answering the question. Questions were
paraphrased as many times as needed to ensure a uniform understanding among the study
participants. No repeat interviews were carried out. Figure 1 shows the semi-structured
interview guide. All but three interviews were anonymously recorded using a digital tape
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recorder. Three participants objected to taped interviews, so the interviewer took notes
during these interview sessions, including verbatim quotes. The interviews lasted an
average of 45 minutes. Recorded interviews were then transcribed by an independent
transcriptionist. Interviews conducted in English were transcribed verbatim. Interviews
conducted in languages other than English were translated and transcribed. The
transcriptions were translated, back translated and reviewed by the interviewer (YMM) to
establish accuracy of the data. The interviewer was fluent in Twi and Ga, but not Ewe.

Data Analysis
Data were analyzed according to principles of Grounded Theory methodology
(39), with the aim to generate hypotheses from the data. All transcribed interviews were
entered and organized using NVivo 9. Each interview was coded by two independent
coders – the interviewer (YMM) and two independent coders. The data were coded using
‘open coding.’ The interviews were coded line by line and a theme was assigned based on
the understood meaning. In order to determine the accuracy of the code assigned,
throughout the analyses the coders compared the segment pertaining to a certain code
with previously coded segments with the same code and analyzed whether they reflected
the same theme, in a process called “constant comparison” (42). The independently coded
interviews were then compared for agreement of the coding assigned. Where there was a
disagreement, the code assignments were discussed between the two coders and the
interviewer, to establish an accepted agreement. All coded interviews were uploaded into
Nvivo 9, and we used the query tool to compare the level of agreement between coders
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for each of the interviews. There was at least 80% agreement between coders for each of
the interviews (42). We sought to ensure the credibility and reliability of the data by
providing an “audit trail’ to the other researchers that is by monitoring and reporting data
collection and analytical processes and procedures fully (39). Reliability was established
by using more than one coder and by review and discussion of the codes among the three
coders, as needed.
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RESULTS

Study participants represented a range of ages, geographical locations and
different stages of breast cancer management (Table 1). Five recurrent themes
characterized the knowledge, beliefs and attitudes about screening mammography and
four were specifically related to why women delay with breast cancer presentation. A
summary of the major themes is presented in Table 2: 1) Most of the women in our study
expressed some, but variable degrees of breast cancer knowledge and screening
recommendations but were unable to translate this information to their personal health; 2)
Symptomatic women often delayed with presentation because they did not associate a
breast lump with breast cancer, often mistaking the lump for a common “boil;” 3) When
diagnosed with breast cancer, most of the study participants failed to follow up for timely
treatment because of the fear that a mastectomy would lead to death and diminished
sexuality; 4) Although not directly associated with late presentation of breast cancer, the
church plays a pivotal role in dissemination of information on breast cancer screening,
referral to oncologists, and provision of emotional and spiritual support during breast
cancer diagnosis and management. For some women the church aided in their decision to
present for breast cancer management; 5) When specifically asked about the influence of
financial limitations on delayed presentation, the study participants discussed the high
cost of chemotherapy treatment. Only two of the respondents explicitly stated treatment
costs as a reason for late presentation. Most of the women in our study had purchased
into the National Health Insurance Scheme (NHIS) introduced by the Ghanaian
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government, and stated that this insurance covered part of the cost of surgical
management, diagnostic imaging and laboratory work, but not chemotherapy and
radiation, which they believed were the most costly aspects of breast cancer management.
We provide verbatim quotations to illustrate each theme.

Theme 1:
Most of the women in our study expressed some, but variable degrees of breast cancer
knowledge and screening recommendations but were unable to translate this information
to their personal health.

Prior to their diagnoses, all but two of the study respondents had heard some
information about breast cancer. The main sources of information identified were the
media (i.e. television or radio) and church-organized health outreach programs. When
asked about knowledge of breast cancer and screening recommendations prior to
diagnosis, one of the study participants said, “I even saw it on a TV program, “Mmaa
Nkomo.” They said women should check every morning for lumps. But when I wake up,
I don’t even think there will be anything there… so I don’t’ check.” Another said, “I
heard an announcement on the radio that all women should go to Korle-Bu [the teaching
hospital where this study was conducted] to have their breasts checked. It was announced
on Peace FM.” Some of the respondents identified church-organized programs as their
source of information, “they come and tell us in the church, before I know that there is
something like that [breast cancer] to check the breasts.”
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The women in our study expressed some awareness of breast cancer but showed
significant variability in their knowledge. A 77-year old grandmother had this to say,
“they usually say that when you put money in your brassiere, you can develop it,” while a
bank executive had this to say, “my knowledge is scanty… all I know is that you can
have some cancerous cells developing, that can start with a lump or something and then it
grows into something else. And then if they detect the lump quickly enough they remove
it and you’re ok, but if it has spread then you have to have another form of surgery.
Sometimes people lose their breasts and they go through chemotherapy and if they’re
able to detect it early enough, it’s treatable, but once it’s advanced there’s no cure for it,
you probably have to be given medication to slow down the rate at which it spreads.” A
few women assigned spiritual causes to the disease. One of the study participants who
had sought interim treatment from a traditional herbalist was told that her breast cancer
was a result of a spell: “he said my husband fought with somebody and that, that person
[cast a spell]… so the spell was meant for my husband but it did not get him so it
attacked me.”
Regardless of the depth of knowledge about breast cancer, the study participants
explained that breast cancer is not discussed in social circles. This silence is further
perpetuated by current breast cancer patients and survivors, who refuse to discuss their
diagnoses. One of the study participants explained that, “I had heard about it [breast
cancer] but I had not seen it with my eyes. I didn’t know anyone who had it….” Another
participant explained that, “I was shy because people would have said that I had brought
a curse on the family especially because it had never happened to anyone. That’s why I
didn’t tell anyone.” The women in our study also commented on the fact that discussing
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their diagnosis inspires gossip. One participant explained, “for some people [breast
cancer patients]... there are spiritual forces [causes] too so you shouldn't talk about it;”
and another explained, “if I should tell them [network of friends], they would be
consumed with fear and there will be too much gossip. I don't want things to spread.”

Theme 2:
Symptomatic women often delayed with presentation because they did not associate a
breast lump with breast cancer, often mistaking the lump for a common “boil.”

Despite some knowledge of breast cancer and screening, most women did not
present with early with breast cancer symptoms. All study participants presented with a
lump and/or some other breast symptom, which most mistook for a “boil.” A boil, which
is a “a localized swelling and inflammation of the skin resulting from usually bacterial
infection of a hair follicle and adjacent tissue, having a hard central core, and forming
pus—called also furuncle (43),” is a fairly common occurrence among Ghanaians (across
the entire population) and it usually resolves spontaneously or after a couple of
applications of western or traditional/herbal topical treatment. One of the participants
who presented five years after noticing her lump said, “It was long ago, about 5 years
ago. But all that while, it was not painful so I used to say it’s just a boil, it will go away
eventually,” and another expressed a similar opinion, “I thought it was a boil and so I was
applying the medicine for boils but it wasn't going away.”
All study participants expressed shock at their diagnosis, and it was inconceivable
to them that what had initially started out as painless breast lump turned out to be breast
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cancer. To summarize, one patient said, “it [the breast lump] was just there, it wasn’t
painful, and no fluid came out of it. So I became surprised because it didn’t seem to
match with any of the breast cancer symptoms that you hear, such as fluids coming out of
the breasts, the color of the breast changing, etc.”

Theme 3:
When diagnosed with breast cancer, most of the study participants did not follow up with
timely treatment because of the fear that a mastectomy would lead to death and
diminished sexuality.

A recurrent theme that emerged in our study was that when women presented to
the hospital and saw an oncologist, who established their breast cancer diagnosis, most of
these women, did not adhere to timely management or absented themselves for varying
lengths of time, before re-presenting at the hospital. This was attributed to the fear of
mastectomy. When probed directly about the fear of mastectomy, women explained that
they believed mastectomy was associated with death. One woman explained, “I thought
because our breasts were next to our chest, one will die when one’s breast gets cut off.”
Another study participant said, “I understand when you do the surgery you will die… so
when I was at the surgical ward, they even booked me for that surgery and I run away.”
Another fear of mastectomy which women expressed very passionately was the
diminished sexuality a woman experiences after mastectomy. An 85 year old widow, who
consented to a mastectomy with little protest, had this to share about the implication of a
mastectomy for younger patients, “I saw young ladies like you who had it [breast cancer]
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and it was very sad because I was thinking there is no way they will get anyone to marry
them. Some of them had one breast. If you have one leg, or one hand you get someone to
marry you but without a breast, you won’t get anyone to marry you! If you don’t have a
husband it is very difficult. That is why the doctor said it is so bad to get the sickness
[breast cancer] at a young age.” One woman in our study whose final decision was to
forgo mastectomy expressed her concern in this way, “a woman's glory is her breast, so
what is your use if one of your breasts is not there? I will rather die with my two breasts
than live with one.” There was one case in which a woman who had initially consented to
a mastectomy expressed regrets about the procedure because of the impact of the surgery
on her marriage. She reported, - “my husband even wanted a divorce because he said I
had been maimed.”

Theme 4:
Although not directly associated with late presentation of breast cancer, the church plays
a pivotal role in dissemination of information on breast cancer screening, referral to
oncologists, and provision of emotional and spiritual support during breast cancer
diagnosis and management. Some respondents stated that the church aided in their
decision to present for breast cancer management.

All of the women in our study identified with a religious group. All but one, who
was a Muslim, identified as Christians. Most of the respondents attended church/mosque
on a regular basis. Although the women in our study did not directly mention the church
(or their faith) as reason for delayed presentation, a recurrent theme was the influential
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role of the church during various stages of their diagnosis and management. For most
participants, the church was aware of their breast symptoms and involved in some aspect
of their disease prior to presentation to the hospital. For some of these women, a church
leader, or an individual in church encouraged them to present to the hospital with their
symptoms or recommended them to an oncologist at the KBTH clinic. One of the study
participants stated that part of the reason why she eventually presented to the hospital
with the breast lump was, “when I showed it to the nursing sister at church, she even told
me that it wasn’t really anything and that the doctors could operate on it and have me
come back home right away but the tests showed that it was cancerous even though it was
small.” Another study participant stated that: “I told my pastor and then he recommended
Dr. X.” And even for those who independently arrived at the decision to seek medical
follow-up, they still turned to the church for support before presenting to the hospital.
One of the study participants said, “I told my superintendent minister and my pastor, who
prayed for me before coming to Korle-Bu [the teaching hospital where this study was
conducted].”
Although the study participants had expressed their reluctance to discuss their
diagnoses publicly or within social circles, our study reveals that women diagnosed with
breast cancer felt confident in discussing their diagnosis with church affiliates. One study
participant when specifically asked about this said, “Only the pastor knows. I've told
other people I'm sick but only the pastor knows exactly what is going on.”

Theme 5:
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When specifically asked about the influence of financial limitations on delayed
presentation, the study participants discussed the high cost of chemotherapy treatment.
Only two of the respondents explicitly stated treatment costs as a reason for late
presentation. Most of the women in our study had purchased into the National Health
Insurance Scheme (NHIS) introduced by the Ghanaian government, and stated that this
insurance covered part of the cost of surgical management, diagnostic imaging and
laboratory work, but not chemotherapy and radiation, which they believed were the most
costly aspects of breast cancer management.

Given that Ghana is a resource-poor country, the study participants were asked
directly how cost of care influenced delayed presentation. Only two of the study
participants identified this as a reason for absenting themselves or delaying treatment.
One of the study participants expressed this financial barrier as such: “Immediately I
went to the lab and came here, they immediately scheduled me for surgery. I didn’t have
money so I went home and never came back because I didn’t have money… I run away
because of the money.” One of the study participants, a trader, explained the difficult
financial choice she had to make, which subsequently resulted in her delayed
presentation: “…at the time I discovered this lump in my breast, my daughter had just
been accepted into Legon [one of three main universities in Ghana] to study nursing… I
didn’t come [follow up with treatment] because I wouldn’t have been able to work to
provide [financially] for my child and I would have destroyed her life… so I wanted to
her to go because I knew that even if I had passed away, she would have entered the
University.”
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Most of the study participants however, discussed the enormous financial burden
of cancer management and specifically remarked that chemotherapy drugs were too
expensive. Majority of the study participants who were in low-income jobs received
significant financial assistance from the church. When probed about the extent of
financial assistance offered by the church, one of the study participants said, “so they
gave me my bill [for chemotherapy] and I gave it to the church so they appealed for funds
and that is what I used to pay it off. I paid 425 GH¢ cedis [~$300]”
Almost all the women indicated that they had purchased the NHIS, however they
expressed frustration regarding the limited coverage of this insurance plan. To summarize
the general theme, one study participant said, “I have health insurance but it doesn’t
cover much. It covers x-ray and it covers lab. But it doesn’t cover anything here [i.e.
chemotherapy and radiation therapy].

Specific questions with regards to transportation revealed that 25.8% of study
participants traveled from outside of Accra, to seek treatment at the Korle-Bu Teaching
Hospital, which is located in the capital city, Accra (Table 1). Consequently, these
patients had to make arrangements for home care and also arrangements for housing
while in Accra for treatment. However, this was not explicitly stated by any of the
women in our study as a reason for delayed presentation and management.
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DISCUSSION

We found that all respondents had some prior knowledge of breast cancer through
the media (i.e. television and radio) and church outreach programs. However, none of the
study participants attended screening (either screening mammograms or clinical breast
exams) and consequently these patients presented with late stage disease. An interesting
fact to note is that 41.9% of the patients in our study were diagnosed before age 40 (Table
1), and would not have met current recommendations for screening. In all cases patients
had a palpable lump or other breast symptom at the time of presentation. 96.8% of study
participants presented with at least a breast lump (Table 1). We found that lack of
familiarity with the association between a breast lump and breast cancer, and fear of
mastectomy, were the main reasons why women delayed with breast cancer presentation
and timely management respectively. Although a previous study (25) had documented
reasons why women report late or do not return for treatment, our findings provide
further insight into the complex ways in which social factors and cultural beliefs interact
and result in delayed presentation and follow up for surgical and medical management of
breast cancer.
Our findings suggest there is some breast cancer awareness. The fact that women
delay with presentation indicates that the information received does not accurately
translate into action with respect to their personal health. The recurrent belief that a
painless breast lump is unlikely to be breast cancer, suggests a need to improve
knowledge about breast cancer symptoms in this population. Our findings also suggest
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that despite the availability of information, there is no talk of breast cancer in social
circles, with most women stating that they have never seen anyone with breast cancer.
This lack of an informed social network may contribute to the knowledge deficit,
particularly the tendency to think of breast lumps as relatively harmless rather than a
symptom of breast cancer. This could explain the gap between some breast cancer
awareness and the inability of study participants to translate this awareness into
meaningful health benefit (i.e., with respect to early detection) on an individual level.
This study also provides important insights as to why mastectomy is not widely
accepted and may contribute to delay in presentation when symptomatic and avoidance of
surgical management once a diagnosis of breast cancer has been confirmed. To our
knowledge, no study has described the role of sexuality as a prominent barrier to
diagnosis and treatment of breast cancer within this population.
Given the recent reports of interest in cancer in developing countries, and new
efforts to put cancer management as well as other chronic diseases on the global health
agenda, our findings have important implications for the design and implementation of
sustainable and effective breast cancer control programs. Specifically for Ghana, this
research provides information that may identify the deficits in the existing breast cancer
education, screening and management efforts by the government and NGO’s. Our
findings suggest that the church has a positive influence on women’s decisions to present
and follow up with breast cancer management. The church is also a safe space for breast
cancer dialogue. Although most women were uncomfortable discussing their breast
cancer diagnosis with extended family and friends, some of them shared information
about their diagnosis with their religious leaders. It is therefore perceivable that women
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would benefit from a network of breast cancer patients and survivors who are members of
their religious group. Although only a few women mentioned an association with a
survivor’s support group, a religious-centered survivorship program may be well-utilized
and could aid in diffusing some of the myths and silence surrounding breast cancer. This
set-up will augment current efforts to provide support for breast cancer survivors.
Additionally, spiritual, emotional and financial support can continue to be concurrently
offered by the church for these women with breast cancer.
Our study also reveals that most participants had purchased the NHIS, introduced
by the government of Ghana in 2003. The premium for this insurance scheme ranges
from GH¢7.2 (~$5) to GH¢48 (~$34). Based on the information gathered, patients
depend on the insurance coverage of laboratory tests and diagnostic scans, but continue to
express concern about the financial burden of chemotherapy and radiation management
of breast cancer. We believe these findings inform future studies of larger populations,
with the aim to understanding health insurance needs relevant to breast cancer
management.
Although several novel themes emerged from this study, our findings should be
interpreted in light of the fact that the qualitative study has some limitations: We
employed purposive sampling to specifically identify women who would inform our
research question. We only interviewed women seen at the self-referral clinic at KBTH,
which also represents another level of selection bias. Additionally, the attitudes,
knowledge, and experiences identified from the patients we studied may not be
generalizable to the entire population since these are women who, despite delays,
eventually did present for follow up and management of their breast lump. There is likely
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an unquantifiable group of women who do not present at all, thus these results cannot be
extrapolated to the general population. Specifically for non-participants, financial
hindrance to presentation and management could be even more significant than that
reported here. Future quantitative studies of larger populations would provide a more
representative picture of the breast cancer experience of Ghanaian women.

Our research has several strengths. In person, one-on-one in-depth interviews
facilitated an open and candid discussion. Additionally, we used several recommended
strategies to ensure reliability, including audio-taping of almost all the interviews,
independent development of coding scheme and follow up comparison between coders
and maintenance of an audit trail to document analytical processes and procedures (39,
44).

With new global emphasis on moving cancer care and funding up the global
health agenda (1, 3, 45), our research highlights that understanding and addressing the
social and cultural influences on the breast cancer experience of Ghanaian women, and
presumably women in other sub Saharan countries, will aid in the design of effective
cancer control programs.
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Figure 1: Semi-Structured Interview Guide
1. What do you know about breast cancer and screening?
2. What do you believe is the cause of breast cancer?
3. Tell me about your breast cancer experience?
a. Probe about screening habits, symptoms at presentation, and time
course of their diagnosis and treatment.
b. How long did you wait to see a doctor? Why is that?
c. How did you feel when you were initially diagnosed, and what
were your major concerns? Explain what influenced your decision
to pursue management?
4. Did you tell others about your breast cancer diagnosis? What exactly did you tell
them? How has your diagnosis changed the way people perceive you?
5. What support systems of groups of individuals influenced your decision to present
and pursue treatment?
6. How did the cost of care influence your time course of presentation to the clinic
and your management decisions?
7. Is there anything else that you can share with me that might better help me
understand the factors that influenced your delay in presenting and seeking
care for breast cancer?
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Table 1:
Descriptive Data among Recently Diagnosed Breast Cancer Patients Seen at Korle-Bu
Teaching Hospital, Accra, Ghana between June to August 2008.
N = 31 (unless otherwise noted)

CHARACTERISTIC

n (%)

Age

(years)

Age Range

25 - 85

Mean Age (SD)

47.12 (31.86 – 62.38)

Median Age

48

Age Groups (years)

(n)

</= 30

4 (12.9)

>30- 40

10 (32.3)

>40-50

6 (19.4)

>50-60

6 (19.4)

>60-70

2 (6.5)

>70

3 (9.7)

Breast Cancer Symptoms at Presentation

(n)

(of note, some patients reported multiple
symptoms; only the first symptom reported
is recorded)
Breast lump

30 (96.8)

Nipple discharge

3 (9.7)
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Swelling

1 (3.2)

”Heavy breasts”

1 (3.2)

Rash

1 (3.2)

Burning sensation in breasts

1 (3.2)

Breast Cancer Treatment

N = 31 (%)

(self-report)
Neo-adjuvant Chemotherapy

4 (12.9)

Adjuvant Chemotherapy

13 (41.9)

Lumpectomy

5 (16.1)

Mastectomy

11 (35.5)

Surgery (extent unknown by patient)

1 (3.2)

Therapeutic Radiation

8 (25.8)

Awaiting treatment plan

3 (9.7)

Occupation

N = 31 (%)

Hotel clerk/Secretary

2 (6.5)

Nurse’s assistant/nurse/pharmacy attendant

4 (12.9)

Farmer/Fish monger

3 (9.7)

Trader/Retailer

8 (25.8)

Banking executive/Marketing manager

2 (6.5)

Retired/Unemployed

8 (25.8)

Caterer/Seamstress

2 (6.5)
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Teacher

2 (6.5)

Patient commute to KBTH, Accra
Participants living in Accra

23 (74.2)

Participants living outside of Accra

8 (25.8)
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Table 2: Summary of Major Themes
1 There is some awareness of breast cancer, but with varying depths of knowledge.
2 Participants present with late stage breast cancer because of the lack of association
between breast lump and breast cancer.
3 Delayed breast cancer treatment is because of the fear of mastectomy.
4 Religion has a positive influence on breast cancer presentation and treatment. It also
plays an important supportive role.
5 Financial reasons were not explicitly related to delayed presentation and treatment.
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